Gilead Sciences settles patent disputes with Lupin, Cipla and 3 others over HIV, Hepatitis B drugs generic versions

The generic drugmakers argued that the patents were invalid and unenforceable. They said in an August court filing that Gilead's patents covered "routine and predictable" variants of a "compound it...

Related Keywords

Delaware ,United States ,California ,Foster City ,Adrienne Kosak ,Stephen Auten ,Joseph Kim ,Christopher Sorenson ,Dennies Varughese ,Maryellen Noreika ,Sterne Kessler Goldstein Fox ,Neal Seth ,Andrew Larsen ,Jonathan Bachand ,William Zimmerman ,Knobbe Martens Olson ,Richard Ruzich ,Taft Stettinius Hollister ,Jefferson Boggs ,Ian Scott ,Cipla Ltd ,Macleods Pharmaceuticals Ltd ,Gilead Sciences ,Drug Administration ,Us District Court ,Hetero Labs Ltd ,Lupin Ltd ,Cipla ,Apotex Inc ,Judge Maryellen Noreika ,California Based Gilead ,Juanita Brooks ,Taft Stettinius ,Andrea Cheek ,Sterne Kessler Goldstein ,Generic Version ,Shiv ,Descovy ,Odefsey ,Hepatitis B ,Vemlidy ,Capotex ,Lupin ,Macleods Pharma ,Hetero Labs ,Usfda , ,